STIM1 and breast cancer: The results gathered in the present investigation demonstrate that Tam rapidly and reversibly triggers the nuclear relocation of TFEB in breast cancer cells of the luminal A subtype by triggering lysosomal Ca2+ mobilization through TPCs and TRPML1, which therefore emerge as potential new molecular targets to prevent Tam resistance in breast cancer.